Evidence map›Paper›PMID 40156902›Full record

ArticleAmerican journal of hypertension2025

Trends in Hypertension Prevalence, Awareness, Treatment, and Control Among US Young Adults, 2003-2023.

Rui Tang, Jaejin An, Brandon K Bellows, Andrew E Moran, Yiyi Zhang

Abstract read
In one paragraph

Article in American journal of hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Can we better prevent cardiovascular disease? 'Stayin' healthy to stay alive'.International journal of cardiology. Cardiovascular risk and prevention · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Isolated diastolic hypertension: methodological and clinical considerations.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Article
  15. Trends and disparities in mortality due to hypertensive disease and coexisting obesity in the USA: 1999-2023.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2025
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Rui TangDivision of General Medicine, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0009-0003-8076-9118
Jaejin AnDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
Brandon K BellowsDivision of General Medicine, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0000-0003-1395-6047
Andrew E MoranDivision of General Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Yiyi ZhangDivision of General Medicine, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0000-0002-8663-5001

Funding

Improving Blood Pressure Screening and Treatment Strategies in Young AdultsR01HL158790 · NHLBI · KAISER FOUNDATION RESEARCH INSTITUTE · PI AN, JAEJIN, ZHANG, YIYI · 2021 to 2025
$3.5M
Improving Lipid Management Strategies in Young AdultsR01HL168379 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Jaejin An, Yiyi Zhang · 2023 to 2026
$2.9M
NHLBI NIH HHS R01HL158790NHLBI NIH HHS R01HL168379NIH
6 · The paper itself

Abstract

backgroundThis study evaluated recent trends in hypertension prevalence and management among US young adults, and assessed disparities by age, sex, or race and ethnicity, as well as potential factors contributing to the age-related disparities.

methodsData from 51,291 adults aged ≥18 years in the National Health and Nutrition Examination Survey 2003-2004 to 2021-2023 were analyzed. Stage 1 or 2 hypertension was defined as systolic/diastolic blood pressure (BP) ≥130/80 mmHg or antihypertensive medication use. Hypertension awareness and treatment were based on self-report.

resultsIn 2021-2023, 21.3% (20.4 million) young adults aged 18-39 years had stage 1 or 2 hypertension, of whom only 28.3% were aware of their condition and 5.6% achieved BP control to <130/80 mm Hg. While hypertension prevalence among young adults remained stable from 2003-2004 to 2021-2023, awareness and control declined after 2013-2014, though no apparent change in control rates was observed between 2017-2020 and 2021-2023. Compared to adults aged ≥40 years, young adults had lower rates of awareness, treatment, and control, with lower rates of having a routine place for healthcare explaining 7%-16% of the gaps. Disparities in hypertension awareness, treatment, and control were greatest among young adult men, non-Hispanic Black, and Hispanic individuals compared with other sex and racial and ethnic subgroups.

conclusionsIn 2021-2023, one in five US young adults had hypertension, yet awareness and control have declined since 2013-2014 and remain low.

Indexed as

Antihypertensive AgentsBlood PressureHealth Knowledge, Attitudes, PracticeHypertensionAdolescentAdultAge FactorsAwarenessFemaleHealthcare DisparitiesHumansMaleMiddle AgedNutrition SurveysPrevalenceTime FactorsAntihypertensive Agentsblood pressuredisparitieshypertensionNHANESprevalenceyoung adults

Identifiers

PMID40156902
PMCPMC12260163

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.